Application of an [18F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy

Journal of Surgical Research

Volumn 96, Issue 1, 2001, Pages 120-126

  Essner, Richard ^a   Hsueh, Eddy C ^a   Haigh, Philip I ^a   Glass, Edwin C ^b   Huynh, Young ^a   Daghighian, Farhad ^c  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b SAINT JOHN'S HEALTH CENTER   (United States)

^c IntraMedical Imaging LLC   (United States)

Author keywords

Gamma probe; Positron emission tomography; 18F fluorodeoxyglucose

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTRAOPERATIVE PERIOD; MELANOMA; METASTASIS; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION MEASUREMENT; RADIOACTIVITY;

EID: 0035746433     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.6069     Document Type: Article

References (40)

1. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax
2. Surgical resection for melanoma metastatic to the gastrointestinal tract
3. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection
4. Patient selection for hepatic resection of colorectal metastases
5. Selection factors resulting in improved survival after surgical resection of tumors metastatic to the lungs
6. 18F-2-Deoxy-2-fluoro-D-glucose uptake into human tumor xenografts: Feasibility studies for cancer imaging with positron-emission tomography
7. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma
8. 18F) fluorodeoxyglucose in management of recurrent colorectal cancer
9. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-deoxy-D-glucose in recurrent colorectal cancer
10. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma
11. Malignant melanoma: Staging with whole body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose
12. Positron emission tomography in the detection and management of metastatic melanoma
13. A review of the literature for whole-body FDG PET in the management of patients with melanoma
14. Standardized probe directed sentinel node dissection in melanoma
15. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
16. Tc-99m sestamibi exam finds niche in breast disease
17. 99m-Technetium sestamibi localized solitary parathyroid adenoma as an indication for limited unilateral surgical exploration
18. Tumor detection with radiopharmaceuticals
19. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer
20. Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer
21. Radioimmunoguided surgery for colorectal cancer
22. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer
23. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases
24. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients
25. Endoscopic ultrasonography in the diagnosis, staging and follow-up of esophageal and gastric cancer
26. Structure distribution and relationship of iodine-123 iodobenzamides as tracers for the detection of melanotic melanoma
27. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma
28. Localization of malignant melanoma using monoclonal antibodies
29. Clinical utility of external immunoscintigraphy with IMMU-4 technetium-99m Fab′ antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: Results of a pivotal, phase III trial. The Immunomedics study
30. PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis
31. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors
32. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake
33. Radiation detector probes for tumor localization using tumor seeking radioactive agents
34. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with radiolabeled glucose analog 2-(F-18)-fluoro-2-deoxy-D-glucose
35. Intraoperative beta probe: A device for detecting tissue labeled with positron or electron emitting during surgery
36. A dual detector probe for gamma ray guided intraoperative beta imaging
37. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
38. 18Fluoro-deoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer